LimFlow, Now Part of Stryker

medical devices

About

LimFlow is a medical technology company focused on innovative treatments for Chronic Limb-Threatening Ischemia (CLTI), a severe form of peripheral artery disease. The company aims to provide effective solutions for patients at risk of amputation due to critically reduced blood flow to the limbs. LimFlow has developed a minimally invasive procedure that reroutes blood flow through the veins below the knee, effectively turning a vein into an artery to restore oxygen and nutrients to the affected limb. The core product, the LimFlow System, includes proprietary technologies such as ultrasound catheters and specialized stents. This FDA-approved system is designed for patients with unreconstructible arteries, offering a permanent bypass solution. LimFlow also provides clinical education and support to healthcare professionals, enhancing therapy adoption and improving patient outcomes. As part of the Inari Medical family and integrated within Stryker, LimFlow benefits from extensive resources to further its mission of improving outcomes for patients with severe vascular disease.

Technologies

CSC Corporate DomainsMailchimp MandrillOutlookMicrosoft Office 365RemoteAI

Keywords

critical limb ischemiawound healingamputation freeendovascularperfusionvenous arterializationdesert footdiabetic footrutherford 5rutherford 6cli fightermedical equipment manufacturingperipheral artery disease treatmentarterial bypass technologyvascular intervention innovationarterial bypass systemminimally-invasive procedurevascular surgery alternativevascular disease treatmentchronic limb ischemiadeep vein arterialization systemvascular systemmedical equipment and supplies manufacturingblood flow bypassvascular healthvascular intervention systemmedical deviceb2bvascular bypass systemperipheral artery disease

Location

6001 Oak Cyn, Irvine, California, United States, 92618

Related Companies

Companies in the same industry